Combining IT and OT software to solve manufacturing’s most frequent challenges
PTC and Rockwell Automation combine technologies to accelerate customers’ digital transformation initiatives.
PTC and Rockwell Automation have demonstrated the unparalleled value of their combined technologies, addressing the most costly and persistent challenges manufacturers face today. Enabled by FactoryTalk InnovationSuite, powered by PTC, the companies’ approach simplifies how manufacturers achieve business outcomes that transform operational processes, workforce productivity and efficiency.
Digital transformation, which uses new technology to spur innovation and creativity, has become imperative for manufacturers facing shifting customer expectations, uncertain global trade and cost pressures, and workforce shortages. Despite the many competitive advantages it can provide, less than 10% of industrial companies describe their own digital transformation efforts as a real success, according to LNS Research. Those who are successful have an expansive, company-wide scope and are deploying solutions that tackle broader challenges, such as understanding true performance across facilities with different environments and systems or minimizing unplanned downtime across their organizations.
“Manufacturers today require a new way to approach pressing challenges. That’s why our combined Rockwell Automation and PTC solutions bring together transformational technologies and drive true business outcomes,” said John Genovesi, senior vice president, Enterprise Accounts and Software, Rockwell Automation.
Since becoming strategic partners last year, the two companies have aligned resources, delivered the Factory Talk Innovation Suite, powered by PTC, and won new business in a variety of countries and industries.
“Our collaboration with Rockwell Automation enables industrial enterprises to overcome challenges and gain traction with their digital operations initiatives,” said Howard Heppelmann, general manager, connected operations solutions, PTC. “We are excited to continue offering solutions that streamline the convergence of digital, physical and human elements – all of which are key to helping our customers digitally transform.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance